{"authors": [["Bower", "James H", "JH", "Department of Neurology, College of Medicine, Mayo Clinic, Rochester, Minnesota, USA."], ["Grossardt", "Brandon R", "BR", "Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, Minnesota, USA."], ["Rocca", "Walter A", "WA", "Department of Neurology, College of Medicine, Mayo Clinic, Rochester, Minnesota, USA."], ["Savica", "Rodolfo", "R", "Department of Neurology, College of Medicine, Mayo Clinic, Rochester, Minnesota, USA."]], "doi": "10.1002/mds.27256", "date": "2018-01-16_23:18:27", "journal": ["Movement disorders : official journal of the Movement Disorder Society", "Mov. Disord."], "year": null, "title": "Prevalence of and indications for antipsychotic use in Parkinson's disease.", "id": "29278275", "text": ["prevalence", "patients", "pd", "taking", "antipsychotics", "measure", "prevalence", "patients", "pd", "taking", "used", "medical", "system", "rochester", "epidemiology", "project", "study", "use", "antipsychotic", "medication", "persons", "parkinson", "disease", "olmsted", "county", "minnesota", "1", "january", "296", "patients", "pd", "olmsted", "county", "1", "january", "2006", "overall", "prevalence", "antipsychotic", "use", "29", "296", "28", "29", "patients", "dementia", "initiating", "antipsychotics", "frequent", "indication", "20", "28", "psychosis", "behavior", "threatening", "patient", "prevalence", "antipsychotic", "use", "patients", "pd", "lower", "expected", "previously", "reported", "cumulative", "incidences", "dementia", "highly", "prevalent", "starting", "antipsychotics", "patients", "antipsychotics", "reasonable", "ratio", "taking", "2017", "international", "parkinson", "movement", "disorder", "society"]}